NO992186L - System med forsinket avlevering for syresensitive medikamenter - Google Patents

System med forsinket avlevering for syresensitive medikamenter

Info

Publication number
NO992186L
NO992186L NO992186A NO992186A NO992186L NO 992186 L NO992186 L NO 992186L NO 992186 A NO992186 A NO 992186A NO 992186 A NO992186 A NO 992186A NO 992186 L NO992186 L NO 992186L
Authority
NO
Norway
Prior art keywords
delivery system
acid
barrier
omeprazole
pulsatile
Prior art date
Application number
NO992186A
Other languages
English (en)
Norwegian (no)
Other versions
NO992186D0 (no
Inventor
Vinay K Sharma
Original Assignee
Sharmatek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sharmatek Inc filed Critical Sharmatek Inc
Publication of NO992186D0 publication Critical patent/NO992186D0/no
Publication of NO992186L publication Critical patent/NO992186L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NO992186A 1996-11-06 1999-05-05 System med forsinket avlevering for syresensitive medikamenter NO992186L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74098196A 1996-11-06 1996-11-06
PCT/US1997/020851 WO1998019668A1 (en) 1996-11-06 1997-11-05 Delayed delivery system for acid-sensitive drugs

Publications (2)

Publication Number Publication Date
NO992186D0 NO992186D0 (no) 1999-05-05
NO992186L true NO992186L (no) 1999-05-05

Family

ID=24978866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992186A NO992186L (no) 1996-11-06 1999-05-05 System med forsinket avlevering for syresensitive medikamenter

Country Status (7)

Country Link
EP (1) EP0941074B1 (de)
AT (1) ATE271379T1 (de)
AU (1) AU5179898A (de)
DE (1) DE69729950T2 (de)
NO (1) NO992186L (de)
WO (1) WO1998019668A1 (de)
ZA (1) ZA979937B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774288B1 (fr) * 1998-01-30 2001-09-07 Ethypharm Sa Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
SE9902386D0 (sv) * 1999-06-22 1999-06-22 Astra Ab New formulation
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
EP1108425B1 (de) * 1999-12-16 2005-06-08 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. Neue stabile mehreinheitliche substituierte Benzimidazole enthaltende pharmazeutische Präparate
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US7300668B2 (en) 2001-10-29 2007-11-27 Massachusetts Institute Of Technology System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US8449911B2 (en) 2003-03-12 2013-05-28 Takeda Pharmaceutical Company Limited Drug composition having active ingredient adhered at high concentration to spherical core
CA2547398A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050214371A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
JP2008502740A (ja) * 2004-06-15 2008-01-31 テバ ファーマシューティカル インダストリーズ リミティド ベンズイミダゾール化合物の安定医薬製剤
AR052225A1 (es) * 2004-11-04 2007-03-07 Astrazeneca Ab Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
CN101389317A (zh) * 2005-12-28 2009-03-18 武田药品工业株式会社 控制释放固体制剂
ZA200805646B (en) * 2005-12-28 2009-12-30 Takeda Pharmaceutical Controlled release solid preparation
DE602007004615D1 (de) 2006-06-30 2010-03-18 Boehringer Ingelheim Pharma Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
AU2007286288A1 (en) 2006-08-14 2008-02-21 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
CN104721168A (zh) * 2006-08-25 2015-06-24 贝林格尔·英格海姆国际有限公司 控制释放系统及其制造方法
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
WO2009113090A2 (en) * 2008-01-17 2009-09-17 Alkem Laboratories Ltd. Process for preparing an oral formulation of an acid-sensitive benzimidazole drug
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
MX9600857A (es) * 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.

Also Published As

Publication number Publication date
DE69729950T2 (de) 2005-07-28
WO1998019668A1 (en) 1998-05-14
ZA979937B (en) 1999-05-18
NO992186D0 (no) 1999-05-05
EP0941074A1 (de) 1999-09-15
AU5179898A (en) 1998-05-29
ATE271379T1 (de) 2004-08-15
EP0941074B1 (de) 2004-07-21
DE69729950D1 (de) 2004-08-26

Similar Documents

Publication Publication Date Title
NO992186D0 (no) System med forsinket avlevering for syresensitive medikamenter
DK0673645T3 (da) Farmaceutisk præparat til afgivelse af lægemidler i colon
DE60021604D1 (de) Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben
NO982302L (no) Farmas°ytisk sammensetning
PT1117386E (pt) Administracao enterica e colonica utilizando capsulas de hpmc
NZ237516A (en) Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release
MX9500885A (es) Preparacion farmaceutica para administracion oral.
NO20003640L (no) Ny doseringsform
RU99126869A (ru) Фармацевтический препарат омепразола
IT1246382B (it) Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
US5824341A (en) Composition providing selective release of an active ingredient
MXPA05001243A (es) Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion.
EP1217992A1 (de) Beschichete feste dosierungsformen
AU736357B2 (en) Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient
WO2001078681A1 (en) Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
CA2725437C (en) Compositions and methods for inhibiting gastric acid secretion
US11730708B2 (en) Dosage form for use in treating or preventing of a disease
Allen et al. Effect of single dose of omeprazole on the gastrointestinal peptide response to food
US20210046011A1 (en) Articles and methods for administration of therapeutic agents
US6074669A (en) Controlled drug delivery system for diltiazem
US20060043207A1 (en) Apparatus, kit and related methods for administering substances
HRP20050055A2 (en) Microcapsules for the delayed, controlled release of perindopril
JPH06256166A (ja) 薬物放出制御製剤
SA99190969B1 (ar) صورة جرعة صيدلانية ذات اطلاق نبضي pulsed relrase dosage form تؤخذ عن طريق الفم

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application